학술논문
SAFETY OF SGLT2 INHIBITORS IN ACTIVE CANCER PATIENTS: RATIONALE AND STUDY DESIGN OF TOSCA TRIAL
Document Type
Article
Author
Source
European Heart Journal Supplements: Journal of the European Society of Cardiology; April 2024, Vol. 26 Issue: 1, Number 1 Supplement 2 pii120-ii120, 1p
Subject
Language
ISSN
1520765X; 15542815